Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ichor Medical Systems develops the TriGrid® Delivery System—an integrated and automated electroporation device that enhances intracellular delivery of nucleic acids for vaccines and therapeutics. The technology has been clinically tested and used in multiple partnered programs targeting infectious diseases such as COVID‑19, HBV, HIV; cancer immunotherapy; and biodefense agents. Some programs have advanced to Phase II clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ichor Medical Systems.